Liver cancer on the rise

Annals of Internal Medicine

Volumn 142, Issue 12 I, 2005, Pages 1029-1032

  Wilson, Jennifer Fisher ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN; TUMOR MARKER;

CHRONIC HEPATITIS; EARLY DIAGNOSIS; HEPATITIS B; HEPATITIS C; HUMAN; INCIDENCE; LIVER CANCER; LIVER CELL CARCINOMA; PREVALENCE; PRIORITY JOURNAL; REVIEW; JAPAN; LIVER TUMOR; UNITED STATES;

CARCINOMA, HEPATOCELLULAR; HUMANS; JAPAN; LIVER NEOPLASMS; UNITED STATES;

EID: 20544454121     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-142-12_part_1-200506210-00024     Document Type: Review

References (12)

1. Kojiro M. Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view. Liver Transpl. 2004;10(2 Suppl 1):S3-8. [PMID: 14762831]
2. Di Bisceglie AM. Issues in screening and surveillance for hepatocellular carcinoma. Gastroenterology. 2004;127(5 Suppl 1):S104-7. [PMID: 15508072]
3. Adams PC, Arthur MJ, Boyer TD, DeLeve LD, Di Bisceglie AM, Hall M, et al. Screening in liver disease: report of an AASLD clinical workshop. Hepatology. 2004;39:1204-12. [PMID: 15122748]
4. Ikai I, Itai Y, Okita K, Omata M, Kojiro M, Kobayashi K, et al. Report of the 15th follow-up survey of primary liver cancer. Hepatol Res. 2004; 28:21-9. [PMID: 14734147]
5. Lencioni R, Cioni D, Crocetti L, Franchini C, Pina CD, Lera J, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology. 2005;234:961-7. Epub 2005 Jan 21. [PMID: 15665226]
6. Shiratori Y, Shiina S, Teratani T, Imamura M, Obi S, Sato S, et al. Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus. Ann Intern Med. 2003;138:299-306. [PMID: 12585827]
7. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, et al. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet. 1995;346:1051-5. [PMID: 7564784]
8. Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology. 2004;127(5 Suppl 1):S87-96. [PMID: 15508108]
9. Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM. Obesity and hepatocellular carcinoma. Gastroenterology. 2004;127(5 Suppl 1):S97-103. [PMID: 15508109]
10. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004;127(5 Suppl 1):S27-34. [PMID: 15508094]
11. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut. 2005;54: 533-9. [PMID: 15753540]
12. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004;126: 460-8. [PMID: 14762783]